<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33245625</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2162-3279</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>10</Issue><PubDate><Year>2020</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Brain and behavior</Title><ISOAbbreviation>Brain Behav</ISOAbbreviation></Journal><ArticleTitle>Amyotrophic lateral sclerosis care in Saudi Arabia: A survey of providers' perceptions.</ArticleTitle><Pagination><StartPage>e01795</StartPage><MedlinePgn>e01795</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e01795</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/brb3.1795</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Provision of care for patients with amyotrophic lateral sclerosis (ALS) is complex and requires the contribution of multiple healthcare professionals. Several international ALS care measures were developed to ensure optimal care for ALS patients. We looked at the rate of inconsistency in providing standard ALS care measures in Saudi Arabia (SA).</AbstractText><AbstractText Label="METHODS">A 5-point response survey was distributed to practicing neurologists in SA. They were asked to grade their perceived consistency of accessibility for 19 items of ALS care measures at their center. The list of ALS care measures items was derived from international ALS guidelines.</AbstractText><AbstractText Label="RESULTS">The response rate from neurologists was 47.3% (62/131), and the responses of 39 neurologists who follow ALS cases were included. Most of the selected ALS care measure items, 63.1% (12/19), were perceived by 50% or more of the ALS care providers to be not consistently accessible to their patients. The perception of ALS care providers of the inconsistent accessibility for ALS patients to ALS care measures was high for communication devices (92.3%), supportive equipment such as motorized wheelchairs (76.9%), end-of-life discussion (74.4%), and respiratory monitoring (66.7%).</AbstractText><AbstractText Label="CONCLUSION">Our data show that ALS patients in SA do not have consistent access to the recommended ALS care measures.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. Brain and Behavior published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abuzinadah</LastName><ForeName>Ahmad R</ForeName><Initials>AR</Initials><Identifier Source="ORCID">0000-0001-5442-6734</Identifier><AffiliationInfo><Affiliation>Neuroscience Unit, Neurology Division, Internal Medicine Department, Faculty of Medicine, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuromuscular Unit, King Fahad Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlShareef</LastName><ForeName>Aysha A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Neurology Division, Internal Medicine Department, Faculty of Medicine, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlKutbi</LastName><ForeName>Abdullah</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurology Department, International Medical Center, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bamaga</LastName><ForeName>Ahmed K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Pediatric Department, Faculty of Medicine, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshehri</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurosciences Department, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Algahtani</LastName><ForeName>Hussein</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Neurology Department, King Abdulaziz Medical City, National Guard Hospital, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cupler</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Neurosciences Department, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alanazy</LastName><ForeName>Mohammed H</ForeName><Initials>MH</Initials><Identifier Source="ORCID">0000-0001-5177-8283</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Behav</MedlineTA><NlmUniqueID>101570837</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072141" MajorTopicYN="N">Neurologists</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010465" MajorTopicYN="N">Perception</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012529" MajorTopicYN="N" Type="Geographic">Saudi Arabia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Saudi Arabia</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">care</Keyword><Keyword MajorTopicYN="N">multidisciplinary</Keyword></KeywordList><CoiStatement>Abuzinadah, AlShareef, AlKutbi, Bamaga, Alshehri, Algahtani, Cupler, and Alanazy report no disclosures.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>27</Day><Hour>12</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33245625</ArticleId><ArticleId IdType="pmc">PMC7559620</ArticleId><ArticleId IdType="doi">10.1002/brb3.1795</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Andersen, P. M. , Abrahams, S. , Borasio, G. D. , de Carvalho, M. , Chio, A. , Van Damme, P. , &#x2026; Weber, M. (2012). EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)&#x2013;revised report of an EFNS task force. European Journal of Neurology, 19(3), 360&#x2013;375. 10.1111/j.1468-1331.2011.03501.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03501.x</ArticleId><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen, P. M. , Borasio, G. D. , Dengler, R. , Hardiman, O. , Kollewe, K. , Leigh, P. N. , &#x2026; Tomik, B. (2005). EFNS task force on management of amyotrophic lateral sclerosis: Guidelines for diagnosing and clinical care of patients and relatives. European Journal of Neurology, 12(12), 921&#x2013;938. 10.1111/j.1468-1331.2005.01351.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2005.01351.x</ArticleId><ArticleId IdType="pubmed">16324086</ArticleId></ArticleIdList></Reference><Reference><Citation>Armon, C. (2007). Sports and trauma in amyotrophic lateral sclerosis revisited. Journal of the Neurological Sciences, 262(1&#x2013;2), 45&#x2013;53. 10.1016/j.jns.2007.06.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2007.06.021</ArticleId><ArticleId IdType="pubmed">17681549</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacci, E. D. , Staniewska, D. , Coyne, K. S. , Boyer, S. , White, L. A. , Zach, N. , &amp; Cedarbaum, J. M. (2016). Item response theory analysis of the amyotrophic lateral sclerosis functional rating scale&#x2010;revised in the pooled resource open&#x2010;access ALS clinical trials database. Amyotroph Lateral Scler Frontotemporal Degener, 17(3&#x2013;4), 157&#x2013;167. 10.3109/21678421.2015.1095930</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1095930</ArticleId><ArticleId IdType="pubmed">26473473</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjaminsen, E. , Alstadhaug, K. B. , Gulsvik, M. , Baloch, F. K. , &amp; Odeh, F. (2018). Amyotrophic lateral sclerosis in Nordland county, Norway, 2000&#x2013;2015: Prevalence, incidence, and clinical features. Amyotroph Lateral Scler Frontotemporal Degener, 19(7&#x2013;8), 522&#x2013;527. 10.1080/21678421.2018.1513534</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1513534</ArticleId><ArticleId IdType="pubmed">30265157</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourke, S. C. , Tomlinson, M. , Williams, T. L. , Bullock, R. E. , Shaw, P. J. , &amp; Gibson, G. J. (2006). Effects of non&#x2010;invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: A randomised controlled trial. The Lancet Neurology, 5(2), 140&#x2013;147. 10.1016/s1474-4422(05)70326-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(05)70326-4</ArticleId><ArticleId IdType="pubmed">16426990</ArticleId></ArticleIdList></Reference><Reference><Citation>Caligari, M. , Godi, M. , Guglielmetti, S. , Franchignoni, F. , &amp; Nardone, A. (2013). Eye tracking communication devices in amyotrophic lateral sclerosis: Impact on disability and quality of life. Amyotroph Lateral Scler Frontotemporal Degener, 14(7&#x2013;8), 546&#x2013;552. 10.3109/21678421.2013.803576</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.803576</ArticleId><ArticleId IdType="pubmed">23834069</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly, S. , Galvin, M. , &amp; Hardiman, O. (2015). End&#x2010;of&#x2010;life management in patients with amyotrophic lateral sclerosis. The Lancet Neurology, 14(4), 435&#x2013;442. 10.1016/s1474-4422(14)70221-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(14)70221-2</ArticleId><ArticleId IdType="pubmed">25728958</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordesse, V. , Sidorok, F. , Schimmel, P. , Holstein, J. , &amp; Meininger, V. (2015). Coordinated care affects hospitalization and prognosis in amyotrophic lateral sclerosis: A cohort study. BMC Health Serv Res, 15, 134 10.1186/s12913-015-0810-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-015-0810-7</ArticleId><ArticleId IdType="pmc">PMC4384378</ArticleId><ArticleId IdType="pubmed">25890266</ArticleId></ArticleIdList></Reference><Reference><Citation>Doi, Y. , Atsuta, N. , Sobue, G. , Morita, M. , &amp; Nakano, I. (2014). Prevalence and incidence of amyotrophic lateral sclerosis in Japan. Journal of Epidemiology, 24(6), 494&#x2013;499. 10.2188/jea.JE20140059</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.JE20140059</ArticleId><ArticleId IdType="pmc">PMC4213224</ArticleId><ArticleId IdType="pubmed">25373461</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman, M. , &amp; Zinman, L. (2015). The economic impact of amyotrophic lateral sclerosis: A systematic review. Expert Review of Pharmacoeconomics &amp; Outcomes Research, 15(3), 439&#x2013;450. 10.1586/14737167.2015.1039941</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14737167.2015.1039941</ArticleId><ArticleId IdType="pubmed">25924979</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogden, A. , Greenfield, D. , Nugus, P. , &amp; Kiernan, M. C. (2012). What influences patient decision&#x2010;making in amyotrophic lateral sclerosis multidisciplinary care? A study of patient perspectives. Patient Prefer Adherence, 6, 829&#x2013;838. 10.2147/ppa.S37851</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/ppa.S37851</ArticleId><ArticleId IdType="pmc">PMC3514070</ArticleId><ArticleId IdType="pubmed">23226006</ArticleId></ArticleIdList></Reference><Reference><Citation>Khairoalsindi, O. A. , &amp; Abuzinadah, A. R. (2018). Maximizing the survival of amyotrophic lateral sclerosis patients: Current perspectives. Neurology Research International, 2018, 6534150 10.1155/2018/6534150</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/6534150</ArticleId><ArticleId IdType="pmc">PMC6109498</ArticleId><ArticleId IdType="pubmed">30159171</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;rner, S. , Siniawski, M. , Kollewe, K. , Rath, K. J. , Krampfl, K. , Zapf, A. , &#x2026; Petri, S. (2013). Speech therapy and communication device: Impact on quality of life and mood in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener, 14(1), 20&#x2013;25. 10.3109/17482968.2012.692382</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.692382</ArticleId><ArticleId IdType="pubmed">22871079</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechtzin, N. , Wiener, C. M. , Clawson, L. , Chaudhry, V. , &amp; Diette, G. B. (2001). Hospitalization in amyotrophic lateral sclerosis: Causes, costs, and outcomes. Neurology, 56(6), 753&#x2013;757. 10.1212/wnl.56.6.753</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.56.6.753</ArticleId><ArticleId IdType="pubmed">11274310</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino, G. , &amp; Piccininni, M. (2019). Amyotrophic lateral sclerosis descriptive epidemiology: The origin of geographic difference. Neuroepidemiology, 52(1&#x2013;2), 93&#x2013;103. 10.1159/000493386</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000493386</ArticleId><ArticleId IdType="pubmed">30602169</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta, P. , Kaye, W. , Raymond, J. , Punjani, R. , Larson, T. , Cohen, J. , &#x2026; Horton, K. (2018). Prevalence of amyotrophic lateral sclerosis &#x2010; United States, 2015. MMWR. Morbidity and Mortality Weekly Report, 67(46), 1285&#x2013;1289. 10.15585/mmwr.mm6746a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6746a1</ArticleId><ArticleId IdType="pmc">PMC6289079</ArticleId><ArticleId IdType="pubmed">30462626</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller, R. G. , Anderson, F. , Brooks, B. R. , Mitsumoto, H. , Bradley, W. G. , &amp; Ringel, S. P. (2009). Outcomes research in amyotrophic lateral sclerosis: Lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database. Annals of Neurology, 65(Suppl 1), S24&#x2013;28. 10.1002/ana.21556</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21556</ArticleId><ArticleId IdType="pubmed">19191307</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller, R. G. , Brooks, B. R. , Swain&#x2010;Eng, R. J. , Basner, R. C. , Carter, G. T. , Casey, P. , &#x2026; Tolin, F. P. (2014). Quality improvement in neurology: Amyotrophic lateral sclerosis quality measures. Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 15(3&#x2013;4), 165&#x2013;168. 10.3109/21678421.2013.875706</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.875706</ArticleId><ArticleId IdType="pubmed">24707820</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller, R. G. , Jackson, C. E. , Kasarskis, E. J. , England, J. D. , Forshew, D. , Johnston, W. , &#x2026; Woolley, S. C. (2009a). Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence&#x2010;based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 73(15), 1218&#x2013;1226. 10.1212/WNL.0b013e3181bc0141</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181bc0141</ArticleId><ArticleId IdType="pmc">PMC2764727</ArticleId><ArticleId IdType="pubmed">19822872</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller, R. G. , Jackson, C. E. , Kasarskis, E. J. , England, J. D. , Forshew, D. , Johnston, W. &#x2026; Quality Standards Subcommittee of the American Academy of Neurology (2009b). Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence&#x2010;based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 73(15), 1227&#x2013;1233. 10.1212/WNL.0b013e3181bc01a4</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181bc01a4</ArticleId><ArticleId IdType="pmc">PMC2764728</ArticleId><ArticleId IdType="pubmed">19822873</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozanne, A. , Sawatzky, R. , H&#xe5;kanson, C. , Alvariza, A. , F&#xfc;rst, C. J. , &#xc5;restedt, K. , &amp; &#xd6;hl&#xe9;n, J. (2019). Symptom relief during last week of life in neurological diseases. Brain and Behavior, 9(8), e01348 10.1002/brb3.1348</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.1348</ArticleId><ArticleId IdType="pmc">PMC6710202</ArticleId><ArticleId IdType="pubmed">31287226</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarvonen&#x2010;Schr&#xf6;der, S. , Kaljonen, A. , &amp; Laimi, K. (2018). Disability in amyotrophic lateral sclerosis compared with traumatic brain injury using the World Health Organization Disability Assessment Schedule 2.0 and the International Classification of Functioning minimal generic set. International Journal of Rehabilitation Research, 41(3), 224&#x2013;229. 10.1097/mrr.0000000000000292</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/mrr.0000000000000292</ArticleId><ArticleId IdType="pubmed">30095553</ArticleId></ArticleIdList></Reference><Reference><Citation>Terada, T. , Miyata, J. , Obi, T. , Kubota, M. , Yoshizumi, M. , Yamazaki, K. , &#x2026; Murai, T. (2017). Frontal assessment battery and frontal atrophy in amyotrophic lateral sclerosis. Brain and Behavior, 7(6), e00707 10.1002/brb3.707</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.707</ArticleId><ArticleId IdType="pmc">PMC5474710</ArticleId><ArticleId IdType="pubmed">28638712</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitacca, M. , Montini, A. , Lunetta, C. , Banfi, P. , Bertella, E. , De Mattia, E. , &#x2026; Paneroni, M. (2018). Impact of an early respiratory care programme with non&#x2010;invasive ventilation adaptation in patients with amyotrophic lateral sclerosis. European Journal of Neurology, 25(3), 556 e33 10.1111/ene.13547</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13547</ArticleId><ArticleId IdType="pubmed">29266547</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwicker, J. , Qureshi, D. , Talarico, R. , Bourque, P. , Scott, M. , Chin&#x2010;Yee, N. , &amp; Tanuseputro, P. (2019). Dying of amyotrophic lateral sclerosis: Health care use and cost in the last year of life. Neurology, 93(23), e2083&#x2013;e2093. 10.1212/wnl.0000000000008582</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000008582</ArticleId><ArticleId IdType="pubmed">31672715</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>